These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7984282)

  • 21. Mutual independence of 5-HT(2) and α1 noradrenergic receptors in mediating deficits in sensorimotor gating.
    Baisley SK; Fallace KL; Rajbhandari AK; Bakshi VP
    Psychopharmacology (Berl); 2012 Apr; 220(3):465-79. PubMed ID: 21947334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains.
    Swerdlow NR; Shoemaker JM; Platten A; Pitcher L; Goins J; Crain S
    Pharmacol Biochem Behav; 2003 Apr; 75(1):191-7. PubMed ID: 12759127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.
    Semenova S; Geyer MA; Sutcliffe JG; Markou A; Hedlund PB
    Biol Psychiatry; 2008 Jan; 63(1):98-105. PubMed ID: 17531208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of 5HT1A receptors in the modulation of the acoustic startle reflex in rats.
    Nanry KP; Tilson HA
    Psychopharmacology (Berl); 1989; 97(4):507-13. PubMed ID: 2524858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats.
    Wan FJ; Swerdlow NR
    Psychopharmacology (Berl); 1993; 113(1):103-9. PubMed ID: 7862814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors.
    Geyer MA; Tapson GS
    Neuropsychopharmacology; 1988 May; 1(2):135-47. PubMed ID: 3150805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic tryptophan deprivation attenuates gating deficits induced by 5-HT(1A), but not 5-HT₂ receptor activation.
    Stancampiano R; Frau R; Bini V; Collu M; Carta M; Fadda F; Bortolato M
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1329-35. PubMed ID: 23141373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
    Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
    Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats.
    Johansson C; Jackson DM; Zhang J; Svensson L
    Pharmacol Biochem Behav; 1995 Dec; 52(4):649-54. PubMed ID: 8587900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.
    Larrauri JA; Levin ED
    Psychopharmacology (Berl); 2010 Dec; 212(4):551-8. PubMed ID: 20811878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
    Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of nicotinic receptors in the lateral habenula in the attenuation of amphetamine-induced prepulse inhibition deficits of the acoustic startle response in rats.
    Larrauri JA; Burke DA; Hall BJ; Levin ED
    Psychopharmacology (Berl); 2015 Aug; 232(16):3009-17. PubMed ID: 25912180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.
    Liechti ME; Geyer MA; Hell D; Vollenweider FX
    Neuropsychopharmacology; 2001 Mar; 24(3):240-52. PubMed ID: 11166515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the 5-HT2C/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose levels of rats.
    Sugimoto Y; Yamada J; Yoshikawa T; Horisaka K
    Eur J Pharmacol; 1996 Jun; 307(1):75-80. PubMed ID: 8831107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.
    Geyer MA; Krebs-Thomson K; Braff DL; Swerdlow NR
    Psychopharmacology (Berl); 2001 Jul; 156(2-3):117-54. PubMed ID: 11549216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonergic modulation of the acoustic startle response in rats during preweaning development.
    Sheets LP; Cook LL; Reiter LW
    Pharmacol Biochem Behav; 1989 Jun; 33(2):415-22. PubMed ID: 2530591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A; Kwek P; Chavez C; van den Buuse M
    J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
    Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
    Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.